𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Manganese-enhanced MRI in a rat model of Parkinson's disease

✍ Scribed by Galit Pelled; Hagai Bergman; Tamir Ben-Hur; Gadi Goelman

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
989 KB
Volume
26
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Purpose

To measure intra‐ and inter‐hemispheric connectivity within the basal ganglia (BG) nuclei in healthy and in unilateral 6‐hydroxydopamine (6‐OHDA) Parkinson disease rat model in order to test the BG interhemispheric connectivity hypothesis.

Material and Methods

The manganese‐enhanced MRI (MEMRI) method with direct injection of manganese chloride into the entopeduncular (EP), substantia nigra (SN), and the Habenula nuclei in unilateral 6‐OHDA (N = 22) and sham‐operated (N = 16) rat groups was used. MEMRI measurements were applied before, 3, 24, and 48 hours post‐manganese injection. Signal enhancements in T1‐weighted images were compared between groups.

Results

Manganese injection into the EP nucleus resulted with bihemispheric signal enhancements in the habenular complex (Hab) at both groups with stronger enhancements in the 6‐OHDA group. It also exhibited lower sensorimotor cortex signal enhancement in the 6‐OHDA rat group. SN manganese injection caused enhanced anteroventral thalamic and habenular nuclei signals in the 6‐OHDA rat group. Manganese habenula injection revealed enhanced interpeduncular (IP) and raphe nuclei signals of the 6‐OHDA rat group.

Conclusion

Modulations in the effective intra‐ and interhemispheric BG connectivity in unilateral 6‐OHDA Parkinson's disease (PD) rat model support the BG interhemispheric connectivity hypothesis and suggest a linkage between the dopaminergic and serotonergic systems in PD, in line with clinical symptoms. J. Magn. Reson. Imaging 2007;26:863–870. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

EVP-ABD-enhanced MRI to evaluate diffuse
EVP-ABD-enhanced MRI to evaluate diffuse liver disease in a rat model
✍ Chun S. Zuo; Peter R. Seoane; Morgane Thomsen; Tim Gillis; Edward Meloni; Philli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

## Abstract ## Purpose To evaluate the feasibility of using manganese‐based MR imaging contrast agent EVP‐ABD to detect diffuse liver disease in an established rat hepatitis model. ## Materials and Methods Hepatitis was induced by administration of CCl~4~ in corn oil vehicle to rats intraperiton

Melatonin treatment potentiates neurodeg
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model
✍ Victor Tapias; Jason R. Cannon; J. Timothy Greenamyre 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

## Abstract Parkinson's disease (PD) is characterized pathologically by progressive neurodegeneration of the nigrostriatal dopamine (DA) system. Currently, the cause of the disease is unknown, except for a small percentage of familial cases (<10% of total). The rat rotenone model reproduces many of

Enhancement of rigidity in Parkinson's d
Enhancement of rigidity in Parkinson's disease with activation
✍ Minna Hong; Joel S. Perlmutter; Gammon M. Earhart 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract Rigidity, a cardinal symptom of Parkinson's disease (PD), increases with movement of a contralateral limb. It is unclear whether this effect is specific for movement of a contralateral limb. The goal of this study was to test the hypothesis that ipsilateral or contralateral movement wou

MRI assessment of basal ganglia iron dep
MRI assessment of basal ganglia iron deposition in Parkinson's disease
✍ Lauren I. Wallis; Martyn N.J. Paley; Jacqueline M. Graham; Richard A. Grünewald; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

## Abstract ## Purpose To estimate the levels of basal ganglia iron levels in Parkinson's disease (PD) using the PRIME MR sequence at 3.0 Tesla, in relation to patients' motor symptom severity. ## Materials and Methods Seventy patients with PD and 10 healthy controls underwent assessment of move

Knockdown of GAD67 protein levels normal
Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease
✍ Lazlo Horvath; Ingrid van Marion; Khalid Taï; Troels Tolstrup Nielsen; Cecilia L 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB 👁 1 views

## Abstract ## Background Dopamine depletion of the striatum is one of the hallmarks of Parkinson's disease. The loss of dopamine upregulates GAD67 expression in the striatal projection neurons and causes other changes in the activity of the basal ganglia circuit. ## Methods To normalize the GAD